Abstract
Introduction
In previous publications we reported that cells from the family of dendritic cells reside in the intima of large w x Ž . arteries 1-3 . These vascular dendritic cells VDCs are common in atherosclerotic lesions but their mature forms w x are rare in normal intima [1] [2] [3] .w x VCAM-1 2,9 .
Dendritic cells are intimately associated with T-cells and through their direct contacts, dendritic cells control or w x regulate immune reactions 4-8 . The functional significance of VDCs in atherogenesis is unknown. As members of the dendritic cell family, VDCs can be expected to behave like other well-studied dendritic cells and thus, it is Time for primary review 27 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. ) reasonable to expect that a principal function of VDCs might be antigen processingrpresentation.
Atherosclerotic plaques contain inflammatory infiltrates w x consisting of macrophages and activated T-cells 10-16 . Antigen specific T-cell activation depends on the interac-Ž . tions of T-cell receptors TCR with antigens presented by MHC molecules but how this is realised in atherogenesis is w x unclear 17-20 . Our previous observations that VDCs display ICAM-1 and VCAM-1 in atherosclerotic lesions w x 2,9 imply that VDCs might interact with T-cells leading to the activation of T-cells, since VCAM-1rVLA-4 interw x actions are critical in T-cell activation [21] [22] [23] . Indeed, in our previous electron-microscopic examination, direct conw x tacts between T-cells and VDCs were detected 36 but it remained unclear whether this process is typical or only occasionally occurs. If co-localisation of T-cells and VDCs normally occurs in atherosclerotic lesions, this favours an association between VDC and T-cell function. This hypothesis was examined in the present study.
To examine whether VDCs usually contacted T-cells, analysis of the co-localisation of these cell types in atherosclerotic lesions was required and, therefore, a double immunostaining technique was used. Double immunostaining was used to estimate the frequency of VDCrT-cell co-localisation in different regions of atherosclerotic plaque. This approach for VDC investigation was used for the first time in the present examination. The data obtained were compared with the distribution of ICAM-1, VCAM-1 and HLA-DR expression using sets of serial consecutive sections. This enabled a determination of whether VDCs express cell adhesion molecules and whether VDCs can potentially present antigens in the same areas where they co-localise with T-cells. In the present work we also investigated VDC distribution in the media and adventitia which has not been studied before.
We now report how VDC-dependent T-cell activation in atherogenesis might occur and offer a scheme of the possible migratory pathways followed by VDCs.
Methods

Tissue specimens and routine histology
Arterial wall segments from 26 carotid arteries and 19 aortas were obtained from patients whose ages ranged from 32 to 71 years. The carotid specimens were obtained w x by endarterectomy 25 and the aortic specimens were w x collected during aortic reconstructions 26 . None of these w x specimens had been used in our previous studies 1-3,9,36 . Material was collected in accordance with the principles w x outlined in the Declaration of Helsinki 24 and the present study was approved by the institutional review board of St. Vincent's Hospital, Sydney.
The arterial specimens selected for immunohistochemical investigations included atherosclerotic lesions and areas of the adjacent normal appearing arterial wall. Paraaortic lymph nodes and jugulodigastric lymph nodes near carotid bifurcations were also taken during the operations. For immunohistochemistry, some aortic samples were processed by standard formalin fixation and paraffin embedding. Other unfixed samples were immediately embedded in OCT compound, rapidly frozen in liquid nitrogen and stored at y708C until cryostat sectioning. Paraffin and frozen sections were cut at 5-7 mm thickness and air dried for 45 min. Sections were stained for analysis with Mayer's haematoxylin.
Identification of intimal cells and examination of their antigen characteristics
Vascular dendritic cells in the arterial intima were identified with anti-CD1a and S-100. CD1a is a membrane associated marker and anti-CD1a antibody exclusively w x identifies VDCs in the arterial wall 2,3 . Antibody to nervous tissue protein S-100 is also convenient for identifying VDCs since the arterial intima does not contain neuronal or glial cells and other intimal cells do not stain w x positively with S-100 1-3 . T-lymphocytes in the arterial intima were identified with anti-CD3 and the T-helperrinducer and suppressorrcytotoxic T-cell subsets were identified with anti-CD4 and anti-CD8. Since CD27 is a marker of mature lymphocytes and CD28 is known to prevent w x apoptosis in lymphocytes 27-29 , T-cell activation was examined using anti-CD27 and anti-CD28. Intimal macrophages were identified with anti-CD68 antibody. Endothelial cells were identified by von Willebrand factor. Smooth muscle cells in the arterial intima were identified with antibody to alpha-smooth muscle actin and antibody w x to muscle actin as previously reported 30 . Anti-HLA-DR was used to estimate the capability of cells to present antigens. Anti-VCAM-1 and anti-ICAM-1 were used to evaluate the expression of cell adhesion molecules. The sources and working concentrations of antibodies used are given in Table 1 .
Single staining immunoperoxidase procedure
An analysis was carried out using sets of consecutive parallel sections immunostained with antibodies to CD1a, acteristics to be investigated as we previously reported w x 2,3,9 . In the present study, this approach was expanded by using sets of several serial consecutive sections. This Downloaded from https://academic.oup.com/cardiovascres/article-abstract/37/3/799/321187 by guest on 09 December 2018 ( )enabled the cell composition to be determined in different areas and ICAM-1, VCAM-1 and HLA-DR expression was examined in the same areas.
For single immunostaining, after eliminating endogenous peroxidase activity by 0.3% H O for 5 min and 2 2 treatment when necessary, by 0.1% trypsin in PBS for 5-10 min, the consecutive sections were preincubated with normal goat serum and then tested with one of the antibodw x ies by avidin-biotin complex using the ABC method 31 . The sections were incubated for 30 min with each primary antibody. After washing in tris-phosphate buffered saline, Ž . pH 7.6 TPBS, 10 min , the sections were incubated for 20 min with the appropriate biotin-labelled secondary antibod-Ž ies horse anti-mouse -VECTOR BA-2000, or goat . anti-rabbit -VECTOR BA-1000 . The sections were then washed in TPBS for 5 min and treated with avidin-biotin Ž . complex ELITE -ABC, VECTOR PK61000 for 30 min. After washing for 10 min in TPBS, brown staining was produced by 5 min treatment with 3,3
X -diaminobenzi-Ž . dine DAB . All the incubations were completed at room temperature. For negative controls, the first antibodies were omitted or the sections were treated with an immuno-Ž globulin fraction of non-immune goat serum VECTOR . S-1000 as a substitute for the primary antibody. None of the negative control sections showed positive immune staining. Counterstaining was performed with Mayer's haematoxylin and sections were examined in a Olympus microscope at 10 = 10 and 10 = 40 magnifications. A semiquantitative analysis of the frequency of intimal cells in different areas was undertaken at 10 = 40 magnification.
Double immunostaining procedure
Differing combinations of antigens were analysed using Ž . paraffin S-100rSMA, S-100rCD68 or frozen sections ŽCD1arCD3, S-100rCD4, S-100rICAM -1, S-. 100rVCAM-1 by a double immunostaining technique Ž . DAKO-DOUBLESTAINe Kit System 40, K665 . This kit allows simultaneous staining for detection of two different tissue markers on one section by a combination of mono-and polyclonal antibodies and of the peroxidase-Ž . antiperoxidase PAP and alkaline phosphatase-antial-Ž . kaline phosphatase APAAP technique. Using a rabbit primary antibody in the PAP system with DAB chromogen yields a brown reaction product at the site of the target antigen while a mouse primary antibody in the APAAP system with Fast Red chromogen results in a rose precipitate at the site of the identified antigen. This difference allows the topographical relationships between the two antigens to be observed. For double immunostaining, after eliminating endogenous peroxidase activity by 0.3% H O 2 2 for 5 min and treatment, if necessary, by 0.1% trypsin in PBS for 5-10 min, the consecutive tissue sections were preincubated with normal swine serum and then tested Ž . according to the manufacturer's instructions DAKO . The sections were incubated with the working solution of the two primary antibodies prepared by mixing equal volumes of each antiserum diluted to one-half of the established optimal dilution appropriate for single immunostaining procedure. The sections were then sequentially incubated with the mixture of anti-rabbit and anti-mouse link antibodies, the mouse APAAP immune complex, followed by the rabbit PAP immune complex. Positive and negative controls were carried out according to the DOU-BLESTAIN Kit System manufacturer's instructions. None of the negative control sections showed positive immune staining. Counterstaining was performed with Mayer's haematoxylin.
Results
Selection of specimens for study of VDC r T-cell colocalisation
VDCs were detected in all the samples studied and the pattern of their distribution in the atherosclerotic lesions was similar in the carotid and aortic specimens, consistent w x Ž q . with our previous observations 1-3 . T-cells CD3 were seen in all atherosclerotic lesions studied. T-cell subpopulations were estimated in serial frozen sections stained with anti-CD4 and anti-CD8. Both these T-cell subtypes were present in the atherosclerotic lesions, with their proportions in individual lesions ranging from about equal numbers to three CD4 q cells per one CD8 q cell. Consecutive paraffin sections stained with anti-CD3, anti-CD68, S-100, and anti-SMA were compared to select specimens appropriate for further study of specific cell co-localisation by a double immunostaining procedure. This analysis showed that fatty streaks and non-complicated atherosclerotic plaques contained large numbers of CD68 q and CD3 q cells, intermingled with SMA q cells. Some CD68
q and SMA q cells were identified as foam cells. S-100 q cells were also seen between CD3 q cells, 
q cells, the different cell types were often intermingled and very closely apposed, which precluded determining whether these cells specifically contacted each other or were simply densely packed together. 
In all plaques studied, S-100 q cells were seen in different areas of the plaques but were always more frequent within inflammatory infiltrates and around the necrotic Ž . core, especially in areas beneath the necrotic core Fig. 1 . A semiquantitative method to indicate relative differences was applied and the peculiarities of the distribution of different cell types are summarised in Table 2 .
Peculiarities of VDC r T-cell and VDC r macrophage co-localisation in plaques 3.2.1. Inflammatory infiltrates associated with neoÕascu-larisation
Analysis of single immunostained sections demonstrated that about 90% of inflammatory infiltrates contained S-100 In contrast, analysis of the anti-CD68rS-100 combination showed that in these inflammatory infiltrates, CD68 q cells seldom co-localised with S-100 q cells.
Areas underlying the necrotic core not associated with neoÕascularisation
These areas presented the best opportunity to study cellular co-localisation since most cells were located at least 10 mm apart. Analysis of double immunostained formalin sections showed that more than 60% of co-loca-Ž q . Ž lising cells were macrophages CD68
and VDCs Sq . Ž . 100 Fig. 4 , and that VDCrVDC close apposition was Ž . also prominent 10-30% . Only a few contacts between Ž q . Ž q .
T-cells CD3
and VDCs CD1a were detected in frozen sections of 5 aortic and 9 carotic specimens. The CD1arCD3 examination required frozen sections which gave a much lower resolution than paraffin sections which meant that some T-cellrVDC contacts could have been missed. A few smooth muscle cells were also found in these areas but their close apposition with S-100 q cells were not apparent.
NeoÕascularisation areas without signs of inflammation
A few co-localising CD68 q cells and S-100 q cells were detected in these areas. T-cells were seldom seen and they did not contact other intimal cells while the clustering of VDCs with each other was usual. Typically, these VDCs were located irregularly, even mosaically, around vessels formed by neovascularisation.
Fibrous caps
S-100 q rCD1a q cells were distributed mostly without obvious contact with other cell types. Sometimes when VDCs were present in groups of 2-4 cells they were seen in close association with each other.
VDCs in the media
The present study extended our previous examination of VDC distribution in the arterial wall by including the media and adventitia. In the media of non-atherosclerotic arteries, a few S-100 q rCD1a q cells were detected between smooth muscle cells. Immunostaining with anti-CD68 demonstrated the presence of a few macrophages also. Capillaries in the media were identified by von Willebrand factor-positive immunostaining. Analysis of consecutive sections showed that CD68 q macrophages were always associated with capillaries and these capillaries were continuous with capillaries in the adventitia. Analysis of parallel sections showed that some medial q cells were associated with these capillaries as well but other S100 q rCD1 q cells were located independently from capillaries and were CD68 negative. Double immunostaining with antigen combinations such as S-100rCD68 and S-100rSMA clearly demonstrated that the S-100 q cells were CD68 negative and that in some parts of the media, these S100 q cells were surrounded by Ž . smooth muscle cells only Fig. 5 .
In the media underlying atherosclerotic plaques, theŽ numbers of S100 rCD1a cells increased markedly at . least 2-to 3-fold compared with the adjacent media of nonatherosclerotic areas of the specimens. These S100 q rCD1a q cells were often found in the diminished medial layer underlying complicated atherosclerotic plaques, frequently in direct contact with smooth muscle cells.
VDCs in the adÕentitia
Unlike the intima and media, the adventitia contains nerve endings which stain intensively with S-100 but not with anti-CD1a. The S-100 q nerve twigs with their fine endings and S-100 q cells of nervous origin allowed them to be easily distinguished from VDCs exhibiting a den-Ž . dritic or flame-like shape Fig. 6 . Around the vasa vasorum in the atherosclerotic arterial wall, massive inflamma-Ž tory infiltrates were present which usually in more than .
90% of infiltrates contained S-100 rCD1a cells of typical dendritic cell appearance. Other S-100 q rCD1a q cells were dispersed around the inflammatory infiltrates, sometimes near the media.
Topography of cell adhesion molecules and molecules suggesting cell actiÕation
The present study extended our previous investigation w x of ICAM-1 and VCAM-1 expression 2,9 by comparing the immunopatterns of ICAM-1 and VCAM-1 distribution in the arterial wall.
ICAM-1 and VCAM-1 expressing cells were irregularly distributed throughout the plaques, although in most specimens the patterns of VCAM-1 and ICAM-1 immunoreactivity were similar. In most sections, ICAM-1 and VCAM-1 were widely expressed on the endothelium lining the neovasculature as well as on nonendothelial cells, but few endothelial cells lining the vessel lumen stained positively with antibodies to ICAM-1 and VCAM-1. This expression was most intense in areas where inflammatory infiltrates were associated with neovascularisation and in Ž cells and cell clusters surrounding the necrotic core 
In the media, S-100 q rCD1a q cells were also ICAM-1 and VCAM-1 positive. Intensive ICAM-1 and VCAM-1 expression was detected in the adventitia and was mostly associated with vasa vasorum and inflammatory infiltrates.
In most specimens, the areas expressing cell adhesion molecules also strongly displayed HLA-DR. About half of the CD3 q cells also expressed HLA-DR suggesting that they were activated. Staining of serial sections with anti-CD3, anti-CD27 and anti-CD28 demonstrated that some CD3 q cells in inflammatory infiltrates displayed CD27 and CD28. These areas often corresponded to areas where CD1a q cells co-localised with CD3 q cells. The assessment of serial sections also demonstrated that some CD68 q cells co-localised with CD3 q cells in areas which corresponded to sites of HLA-DR expression. Areas of the adventitia with inflammatory infiltrates also displayed intensive HLA-DR expression.
VDCs in adjacent lymph nodes
Analysis of lymph nodes removed from a site near the atherosclerotic arterial wall demonstrated a large number q Ž . of S-100 dendritic shaped cells Fig. 8 . These cells were located irregularly throughout the lymph nodes but were always found in T-cell associated zones expressing CD3 antigen.
Discussion
The family of dendritic cells consists of various memw x bers located in different organs [4] [5] [6] [7] [8] 32 . Dendritic cells, whether in lymphoid or nonlymphoid tissues, constitute only a minor cell population. In blood, dendritic cells w x represent less than 0.1% of the white blood cells 6,33 . In the epidermis, Langerhans cells represent 3 to 5% of the w x total cell population 6,34 while in spleen cell suspensions w x 1-1.6% are dendritic cells 6,35 . Our previous investigations showed that mature vascular dendritic cells express-Ž ing S100 and CD1a are rarely found in normal non-. w x atherosclerotic intima 1-3 even though immature VDCs w x can often be detected 36 . These immature VDCs can be unambiguously identified by their typical ultrastructural w x features 36 including a tubulo-vesicular apparatus unique to dendritic cells. They are regularly located along the subendothelial layer, and are often in close contact with w x endothelial cells 36 . These observations imply that expression of both S100 and CD1a is associated with the activation and maturation of VDCs. Although we did not perform a precise quantitative analysis of VDCs, we esti-Ž mated that the number of VDCs including both immature . and mature forms in the normal intima is similar to the number of Langerhans cells in the skin, namely, 2 to 5% w x 1,36 . However, in some areas of atherosclerotic lesions, VDCs were estimated to represent about 10% of the total cell population when viewed at 10 = 40 magnification.
Dendritic cells are intimately associated with T-cells w x 4-8 . Since VCAM-1rVLA-4 and ICAM-1rLFA-1 are w x critical in T-cell activation 21-23 , the presence of cell adhesion molecules such as ICAM-1 and VCAM-1 on VDC surfaces implies that VDCs are capable of forming contacts responsible for T-cell activation. In the present work, co-localisation of VDCs and T-cells was demonstrated which suggests that VDCs may be instrumental in T-cell activation and that specific T-cell activation might depend on cell-to-cell contacts involving cell adhesion molecules. The observation that interacting VDCs and T-cells also express HLA-DR favours our speculation that VDCs might be involved in T-cell activation. Although the presence of HLA-DR and co-localisation of VDCs and T-cells suggests an interaction, physical proximity does not necessarily define a functional relationship and thus, the functional significance of VDC-T cell co-localisation requires further clarification.
T-cell involvement in immune responses in atherogenew x sis is well recognised 10-13,16-20 , but whether the T-cells in atherosclerotic lesions respond to a restricted set of antigens or recognise a wide range of epitopes is unclear. Different mechanisms may be involved in the activation of different subtypes of T-cells. Similar to other dendritic cells which typically express high levels of MHC w x w x class II molecules 4-8 , VDCs express HLA-DR 2,3 which might suggest their involvement in antigen presentation. VDCs also display on their surfaces CD1a which has recently been recognised as an antigen presenting molecule in the same sense as the classical MHC class I and II w x molecules 37-39 , and thus an involvement of CD1-restricted responses in atherosclerosis cannot be excluded. Furthermore, the association of VDCs with T-cells may be a secondary response rather than indicating a primary antigen presenting function for VDCs.
In the present examination, VDCs were seen to be irregularly distributed throughout the atherosclerotic lesions which suggests that their distribution and intercellular communications might depend on microenvironmental influences. In atherosclerotic plaques, more than 90% of VDCs co-localising with T-cells were located in neovascularisation areas associated with inflammatory infiltrates. Outside these areas, co-localising VDCs and T-cells were only occasionally or even rarely detected, and contacts between VDCs and macrophages were more usual.
Multiple and close contacts between VDCs and macrophages in atherosclerotic lesions were detected in w x our previous electron microscopic investigation 36 . The present study showed that the co-localisation of these cells mostly occurs in areas not associated with neovascularisation. The VDCrmacrophage co-localisation was especially abundant around the necrotic core where most destruction processes occur. Possibly, this is where antigen presenting cells accept most arterial destruction antigens. The pres- ence of a large number of VDCrmacrophage contacts in this area also may imply that in atherogenesis, interactions between these cell types are essential for processing immune information. Dendritic cells lack endophagocytic w x activity and lysosomal activity 4-8 and VDCrmacrophage co-operation might compensate for these VDC deficiencies. The small number of VDCs contacting T-cells around the necrotic core suggests that to present antigens engulfed and collected within and around the necrotic core, VDCs migrate to other areas where the microenvironment allows T-cellrVDC interactions.
Based on our observations of where VDCs and T-cells frequently co-localised, we identified two arterial wall regions where VDC-dependent T-cell activation might Ž . mostly occur Fig. 1 . First are the zones of neovascularisation associated with inflammatory infiltrates within atherosclerotic lesions. The second region suspected of intensive presentation of immune information by VDCs to T-cells is the areas around the vasa vasorum in the adventitia where inflammatory infiltrates accumulate. That the adventitia might be involved in this process is further supported by our observations of the concentration and co-localisation of large numbers of T-cells and VDCs in these areas and that these areas are characterised by strong HLA-DR expression. The VDCs which were observed in the media may represent VDCs migrating from the intima Ž . to the adventitia Fig. 1 .
The presence of regions in the atherosclerotic intima containing immuno-competent cells together with antigen presenting cells supports the notion of a ' vascular-associated lymphoid tissue' proposed in 1995 by Kleindienst et w x al. 40 . Like the mucosa-associated lymphoid tissues Ž . MALT of respiratory and gastrointestinal tracts, Ž . vascular-associated lymphoid tissue VALT is thought to be designed to screen ' vascular tissue' for potentially w x harmful antigens 40 . We suggest that lymph nodes associated with the arterial wall are a third region where VDCs may activate T-cells. VDCs might share the origin and migratory routes with other well-studied dendritic cells such as Langerhans cells. Dendritic cells mature in different tissue sites from Ž . MHC class II Ia negative bone marrow-derived precurw x sors 6 and develop region-specific characteristics which w x could reflect lineage differences 6,32 . Within nonlymphoid tissues, these precursors apparently develop into Ia q cells with the capacity to take up and process antigens w x 4-7,41 . These cells can migrate into lymphoid tissues and mature into lymphoid dendritic cells with specialised co-stimulatory functions necessary for T-cell activation w x 4-7,42-44 . Dendritic cells can migrate via the blood to the spleen in addition to their documented migratory route via the lymphatics, as veiled cells, into lymph nodes where w x they are known as interdigitating cells [4] [5] [6] [7] 44 .
Our present pilot study of lymph nodes associated with the arterial wall demonstrated a large number of S-100 q cells co-localised with T-cells in lymph nodes. We propose that some of these S-100 q dendritic shaped cells might be interdigitating cells of VDC origin. The distinctive nature of the lymph node interdigitating dendritic cell microenvironment allows interactions between a single presenting w x cell and numerous potential responses 5 which leads us to consider whether lymph nodes are involved in immune mechanisms in atherogenesis. This hypothesis needs further verification including comparing the numbers of interdigitating cells in lymph nodes located on the atherosclerotic arterial wall such as para-aortic and jugulodigastric lymph nodes with those lymph nodes remote from nonatherosclerotic arteries. VDCs might migrate from the intima to the adventitia and thence to lymph nodes, but we cannot exclude an exchange of dendritic cells back and Ž . forth between the arterial wall and lymph nodes Fig. 1 . This possible to-and-fro traffic needs further study.
The results of the present study favour the hypothesis that VDCs are responsible for T-cell activation. Our observations lead us to speculate that the readiness of VDCs to present antigen to T-cells requires a primary interaction of VDCs with intimal macrophages. Some intimal VDCs migrate through the media to the adventitia where they interact with T-cells within inflammatory infiltrates around the vasa vasorum. Local lymph nodes may also be involved in VDCrT-cell interactions. Perhaps, only some VDCs migrate to lymphoid organs while others contact T-cells directly within the intima, since T-lymphocyte-like cells clustering with VDCs were detected in our electron w x microscopic study 36 . 
